Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Diaphragmatic Breathing Exercises on Sleep Disorders un Polycystic Ovarian Syndrome

NCT07698925 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-07-11
Last updated
2026-07-14

Condition(s) studied

Polycystic Ovarian Syndrome (PCOS)Pittsburg Sleep Quality IndexFatigue Severity ScaleInsomnia Severity IndexDiaphragmatic Breathing ExerciseSleep Disorders

Investigational drug(s) / intervention(s)

Diaphragmatic breathing exercisesLifestyle modification advices

Diaphragmatic breathing exercises: Its course is 3 times per week, 6 minutes twice a day, for 8 weeks. When it's the first time to learn how to perform the diaphragmatic breathing technique, it's easier to follow the instructions lying down in supine position with a pillow under head. The patient will be asked to place one hand on her abdomen, just below her ribcage, and the other hand on the middle of her chest to become aware of her diaphragm's position and function during breathing. She will be told to breathe slowly and deeply through her nose and let her abdomen rise as much as possible. The length of the inhalation or exhalation should be 2-3 seconds

Lifestyle modification advices: Avoid caffeine, smoking, alcohol, napping; thirsty or hungry Regular exercising, sleep timing, relax techniques; Reduce noise, Ensure bedroom clean, no TV, mobile in bed, snack near bed, warm bath pre sleep, wear sleep cloths, most relaxed position for sleep.

Study summary

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in females in reproductive age and not completely understood. Women with PCOS appear to have an increased frequency of sleep problems. Diaphragmatic Breathing (DB) exercises has positive effects on improving sleep quality. The purpose of this study will evaluate the effect of diaphragmatic breathing exercises on improving sleep quality in polycystic ovarian syndrome women.

Eligibility

Sex
FEMALE
Min age
25 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Women aged from 25-35 years old, Diagnosed with PCOS by gynecologist, diagnosis of PCOS will be based on the 2003 Rotterdam criteria. * They have a Pittsburgh sleep quality index (PSQI) score greater than 5. * Not participating in any physical exercise for the previous 3 months. * They have an insomnia severity index score greater than 15. * They have a fatigue severity scale score greater than 36. * Ability to use internet and phone services Exclusion Criteria: * • Women with autoimmune diseases and cancer. * Women with neurological, mental, cardiopulmonary and musculoskeletal disorders. * Pregnant or lactating women. * Women who showed regular adherence to sleeping pills, antidepressants and hormonal replacement agents. * Inability to perform diaphragmatic breathing due to physical limitations. * Women who participate or receive any interventions that could affect their sleep

Primary outcome measure(s)

  • Pittsburgh Sleep Quality Index (PSQI) — Pre-treatment at baseline of the study Post-treatment after intervention completed by 8 weeks.
    a reliable, valid, standardized measure of sleep quality, discriminate "good" and "poor" sleepers and provide an easy index for patients to complete. It's classified into seven subcategories: "subjective sleep quality" (1 item), "sleep latency" (2 items), sleep duration (1 item), habitual sleep efficiency (3 items), sleep disturbances (7 items), use of sleeping medication (1 item), and daytime dysfunction (3 items). Five additional questions rated by the respondent's roommate or bed partner are included for clinical purposes and are not scored, all seven-item scores were added together to generate a total score ranging from 0 to 21.

Trial sites (1)

FacilityCityRegionStatus
Cairo University; Faculty of Physical Therapy Cairo Cairo Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07698925 on ClinicalTrials.gov ↗ ← All trials in Egypt